Interest in metformin long COVID research has increased as scientists search for reliable long COVID treatment options. Early studies suggested the common diabetes medication might reduce the risk of persistent illness when taken during the initial stage of infection.
However, more recent research is questioning whether the drug actually improves ongoing long COVID symptoms once they have already developed. Millions of people continue to experience fatigue, brain fog, and breathing difficulties months after infection, making effective treatment a major medical priority.
